Arab Health 2025 - Italian exhibitors catalogue

SF GROUP

EXHIBITOR AT ARAB HEALTH 2025
HALL Z2 - STAND K17
SF GROUP | Exhibitor at Arab Health 2025
AddressVia Tiburtina, 1143
City00156 Roma (RM)
CountryItaly
Phone
Mobile+39-333-2573368
E-mailfares.sawas@sfgroupfarm.com
Websitesfgroupfarm.com/
COMPANY CONTACTS
Fares Sawas - Export manager – International Business Development: fares.sawas@sfgroupfarm.com
COMPANY KEYWORDS
drugs – prescription drugs – pharma – distribution - nutrition
COMPANY PRODUCT GROUPS
Alternative & Herbal Products
Drugs
Pharma/Nutrition - Food for Medical Purposes
Vitamins & Supplements
COMPANY PROFILE
SF GROUP PHARMACEUTICALS
Expanding global health horizons towards the future

Company Overview
SF GROUP PHARMACEUTICALS is an Italian pharmaceutical company recognized as one of the most dynamic players in the industry with +80mil. Turnover (2023). Established in 2004 through the initiative of the Saia family, the company rapidly expanded through strategic acquisitions of entire product portfolios from other pharmaceutical companies and the development of proprietary product registrations and Marketing Authorizations (MAs). Currently, SF GROUP PHARMACEUTICALS holds over 250 MAs, covering a wide range of therapeutic areas.

Mission and Vision
At SF GROUP PHARMACEUTICALS, our mission centers on enhancing individual well-being and health. We are committed to delivering the highest quality products while keeping pharmaceutical expenditure reasonable. We believe that every individual deserves access to safe, effective, and high-quality medications, and we strive to meet and exceed these standards consistently.

Therapeutic Areas
With a robust portfolio of over 250 Marketing Authorizations, SF GROUP PHARMACEUTICALS offers branded products across 11 key therapeutic areas, including:
Antibiotics: Amoxicillin + Clavulanic Acid, Ciprofloxacin, Levofloxacin, Clarithromycin, Cefaclor, Azithromycin Dihydrate, Erythromycin, Cefixime, Cephalexin
Anti-infectives: Ceftriaxone (Lidocaine), Piperacillin+Tazobactam, Ceftazidime, Cefotaxime, Amikacin, Cephazolin, Famiciclovir.
Anti-inflammatory - immunosoppressive drugs: Nimesulide (NSAID), Celecoxib (NSAID), Thiocolchicoside, Hydrocortison, Prednisone, Methotrexate.
Vitamins/Minerals: Alfacalcidol, Calcium Carbonate+Vitamin D3, Sodium Risedronate, Cholecalciferol Antifungals: Miconazole, Fluconazole
Gastrointestinal treatments: Omeprazole, Pantoprazole, Esomeprazole, Rabeprazole, Lansoprazole, Domperidone, Ursodeoxycholic acid
Cardiovascular drugs: Clopidogrel, Simvastatin, Nifedipine, Amlodipine, Doxazosin, Atorvastatin, Ezetimibe, Ezetimibe + Simvastatin, Valsartan/Hydrochlorothiazide, Atenolol, Irbesartan, Rosuvastatin, Ramipril / Amlodipine
Urology-Gynecology: Sildenafil, Tadalafil, Folic Acid
Neurological and Psychiatric medications: Citalopram, Escitalopram, Pregabalin
Respiratory treatments: Flunisolide, Formoterol, Cetirizine, Salmeterol/Fluticasone, Ambroxol Hydrochloride.
Prostate Health: Finasteride, Terazosin, Dutasteride, Tamsulosin.

This extensive portfolio allows us to address a comprehensive range of health needs and support global health initiatives.

Sales and Marketing Excellence
SF GROUP PHARMACEUTICALS provides exceptional sales and marketing support to establish high-quality, EU GMP-compliant products on an international scale. Our tailored marketing approach includes:
Specific marketing plans
Comprehensive market analyses
Targeted market strategies
Defined sales targets and actionable plans
Specialized training for sales and scientific teams
Through these activities, we ensure our marketing efforts align with market demands and drive product growth and market presence.

Regulatory Compliance and International Support
Our dedicated and highly trained regulatory team manages all international product registrations, a core factor in our successful global expansion. We ensure compliance with local laws and regulations in every country we operate, allowing our partners to achieve seamless market entry and sustained growth. This meticulous regulatory coordination is essential to our strategy for sales growth and market consolidation.

Commitment to Public Health
SF GROUP PHARMACEUTICALS is committed to advancing public health by addressing the global demand for innovative, safe, and effective pharmaceutical solutions. Guided by our core values—Transparency, Respect, Integrity, and Science—we work to meet the needs of current and potential pharmaceutical partners for international development with creative, forward-thinking solutions.

Core Values
Transparency: Open communication and clear policies with our partners and clients.
Respect: Ethical practices in all business operations and partnerships.
Integrity: Commitment to quality, honesty, and reliability.
Science: Dedication to advancing public health through evidence-based solutions and continuous innovation.
Through these principles, we strive to make a meaningful impact on international public health.